¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ»êºÎÀΰúÇÐȸ 105Â÷ Çмú´ëȸ : 2019-09-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ»êºÎÀΰúÇÐȸ 105Â÷ Çмú´ëȸ : 2019-09-20
±³À°ÀÏÀÚ : 2019-09-20
±³À°Àå¼Ò : ±×·£µå ÈúÆ° ¼­¿ïÈ£ÅÚ ´ÙÀ̾Ƹóµå Ȧ ¿Ü  
±³À°ÁÖÁ¦ : ´ëÇÑ»êºÎÀΰúÇÐȸ 105Â÷ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑ»êºÎÀΰúÇÐȸ
´ã´çÀÚ : ±Ç³ª¶ó
¿¬¶ôó : 02-3445-2262  
À̸ÞÀÏ : office@ksog.org      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 190,000¿ø      
ºñ°í Á¤È¸¿ø(Àü¹®ÀÇ)- »çÀüµî·Ï: 120,000¿ø/ ÇöÀåµî·Ï: 160,000¿øÁØȸ¿ø(Àü°øÀÇ)- »çÀüµî·Ï: 90,000¿ø/ ÇöÀåµî·Ï: 130,000¿øºñȸ¿ø- »çÀüµî·Ï: 150,000¿ø/ ÇöÀåµî·Ï: 190,000¿øºñȸ¿ø(¿¬±¸¿ø, °£È£»ç)- »çÀüµî·Ï: 100,000¿ø/ ÇöÀåµî·Ï: 140,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-20 ´ÙÀ̾Ƹóµå(3F) 08:20~08:30 Markers for decision-making in severe postpartum hemorrhage : angioembolization vs laparotomy  ±Ç¸í(°è¸íÀÇ´ë) 
±³À°½Ã°£ 09-20 ´ÙÀ̾Ƹóµå(3F) 08:30~08:40 The association between pregnancy conceived after in-vitro fertilization and placental pathologic findings: a retrospective cohort study  ¼ÛÀºÁø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-20 ´ÙÀ̾Ƹóµå(3F) 08:40~08:50 Heterotopic pregnancy operation outcomes  ¾çÀ±¹Ì(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09-20 ´ÙÀ̾Ƹóµå(3F) 08:50~09:00 Summary of clinically diagnosed amniotic fluid embolism and disagreement with structured definition based on 4 criteria proposed for use in research  ±èÁøÇÏ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-20 ´ÙÀ̾Ƹóµå(3F) 09:00~09:10 The effect of maternal preeclampsia on brain in offspring: basic and clinical aspect  ½ÉÀ翵(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-20 ´ÙÀ̾Ƹóµå(3F) 09:10~09:20 Gestational weight gain in twin pregnancies in Korea: application of the 2009 Institute of Medicine recommendations  ÃÖº¸¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-20 ´ÙÀ̾Ƹóµå(3F) 09:20~09:30 Effect of fibronectin on protein expression of ¥á-SMA and collagen in mouse uterine cervical fibroblasts  ¹ÚÁ¤Àº(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-20 ´ÙÀ̾Ƹóµå(3F) 09:30~09:40 The risk of subchromosomal deletion and duplication in pregnancies with abnormal ultrasound findings  ±è¼Ò¿¬(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-20 ´ÙÀ̾Ƹóµå(3F) 09:40~09:50 Comparison analysis of the intact trophoblast cells purity according to the timing of fixation in trophoblast retrieval and isolation the cervix  À̹ÎÁø(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09-20 ´ÙÀ̾Ƹóµå(3F) 09:50~10:00 The difference in the causes of stillbirth according to gestational age: Observation analysis focused on placental pathologic report.  ³ë°æ¿ø(¼º±Õ°üÀÇ´ë) 
È޽Ġ09-20  10:00~10:20 Coffee Break  () 
±âŸ 09-20 ÄÁº¥¼ÇȦ(4F) 10:20~10:40 Àλ縻  ±è½Âö(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 10:40~10:50 ¸ðüžÆÀÇÇР Á¤ÀºÁ¤(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 10:50~11:00 ºÎÀÎÁ¾¾çÇР ±è¹Ì¼±(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 11:00~11:10 ÀϹݺÎÀΰúÇР ÀÌ»ç¶ó(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 11:10~11:30 PreImplantation Factor (PIF): Translational Aspects for Dx and Rx in Pregnancy  Eytan R. Barnea(BioIncept) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 11:30~11:50 The quest for genes conferring risk of endometriosis: Why there are so much heat but not much light?  Sun-Wei Guo(Fudan Univ) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 11:50~12:10 Non Descent vaginal hysterectomy  Chittaranjan N. Purandare(Indian College of Obstetricians and Gynaecologists) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 12:10~12:30 Precision Dinner: My Genome and HealthRecord  ±èÁÖÇÑ(¼­¿ïÀÇ´ë ÀÇÇаú) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 12:30~13:10 Çѱ¹ ¿©¼ºÀÇ °íÀ§Ç豺 HPVºÐ¼®À» ÅëÇØ º» °¡´Ù½Ç9ÀÇ °¡Ä¡  ½Å¼ÒÁø(°è¸íÀÇ´ë) 
½Ä»ç 09-20 ÄÁº¥¼ÇȦ(4F) 13:10~13:40 ½Ä»ç  () 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 13:40~14:00 Treatment of endometriosis in clinically diagnosed patients  ±è¼ºÈÆ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 14:00~14:20 The role of LNG-IUS in peri-menopause  ÀÌÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 14:20~14:40 The effectiveness of sFlt-1 PlGF ratio in preeclampsia  ¹ÚÈñÁø(Â÷ÀÇ°úÇдë) 
È޽Ġ09-20 ÄÁº¥¼ÇȦ(4F) 14:40~15:00 Coffee Break  () 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 15:00~15:30 High-risk HPV test as primary screening for cervical cancer: KSOG and KSGO position statement  ¹ÚÁ¤¿­(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 15:30~15:50 ºÎÀΰú ·Îº¿¼ö¼úÀÇ ¹Ì·¡ Àü¸Á  ¼º¼®ÁÖ(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 09-20 ÄÁº¥¼ÇȦ(4F) 15:50~16:20 ³«Å¹ý °³Á¤ °ü·Ã »êºÎÀΰú ÀÇ·á°èÀÇ ÀÔÀå ¹× À̽´  Ã־ȳª(±¹¸³Áß¾ÓÀÇ·á¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ»êºÎÀΰúÇÐȸ 105Â÷ Çмú´ëȸ : 2019-09-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 1. ¿©¼º¹è´¢Àå¾ÖÀÇ ÃÖ½ÅÁö°ß 2. Practical treatment for UTI by drug-resistant bacteria : 2019-09-20
´ÙÀ½±Û ´ëÇÑ°í°üÀýÇÐȸ 2019³â °í°üÀý °ñÀý ½ÉÆ÷Áö¾ö : 2019-09-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20732 ¼­¿ï Á¦55Â÷ Ç×¹®Áúȯ¿¬±¸È¸ Áý´ãȸ : 2024-06-02 0 22 2024-05-27
20731 °­¿ø ´ëÇÑ°ñÀýÇÐȸ Á¦6ȸ »óÁö °ñÀý ½ÉÆ÷Áö¾ö : 2024-06-02 0 21 2024-05-27
20730 °­¿ø 2024³â °³¿øÀǸ¦ À§ÇÑ ³»°úÇÐ ¿¬¼ö°­Á : 2024-06-02 0 16 2024-05-27
20729 Ãæ³² Á¦16Â÷ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­ ±³À° (»ó¹Ý±â_3ÀÏÂ÷) : 2024-06-02 0 45 2024-05-27
20728 ¼­¿ï 2024³â ´ëÇÑÀÇÇз¹ÀÌÀúÇÐȸ Á¦13Â÷ ¿¬¼ö±³À° : 2024-06-02 0 35 2024-05-27
20727 ¼­¿ï Á¦9ȸ °¡Á¤ÀÇ, È£½ºÇǽº ¿ÏÈ­ÀÇ·á Àü¹®°¡µÇ±â : 2024-06-01 0 58 2024-05-27
20726 ¼­¿ï ÀÌ´ë¼­¿ïº´¿ø »êºÎÀΰú Áö¿ªÀÇ»ç °£´ãȸ(Àӽżº °íÇ÷¾Ð ÁúȯÀÇ Á¶±â ¿¹Ãø°ú ¿¹¹æ) : 2024-06-01 0 72 2024-05-27
20725 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥(ÀÚ±â¾ÖÀû ÀΰÝÀå¾Ö) : 2024-06-01 0 67 2024-05-27
20724 ¼­¿ï °Ç±¹´ëÇб³º´¿ø ´ëÇÑÀÇÁø±ÕÇÐȸ Á¦30Â÷ Çмú´ëȸ : 2024-06-01 0 57 2024-05-27
20723 ¼­¿ï Á¦54Â÷ ´ëÇѼҾƽŰæ¹ß´ÞÇൿ¿¬±¸È¸ ÇмúÁý´ãȸ : 2024-06-01 0 68 2024-05-27
20722 °æ³² Á¦25ȸ °æ³²ÀÇ»çÀÇ ³¯ ±â³ä Á¾ÇÕÇмú´ëȸ[¿Â.¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ] : 2024-06-01 0 98 2024-05-27
20721 ÀüºÏ 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ÀüºÏÁöȸ Á¦12ȸ ¿¬¼ö°­Á : 2024-06-01 0 81 2024-05-27
20720 ¼­¿ï 2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-01 0 60 2024-05-26
20719 ºÎ»ê Á¦516Â÷ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³²Áöȸ Çмú´ëȸ : 2024-06-01 0 69 2024-05-26
20718 °æ±â Àü¹®½ÉÀå¼Ò»ý¼ú(ACLS Provider) ½Ã¹Ä·¹À̼Ç(2day) : 2024-06-01 0 48 2024-05-26
31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷